Search results for "EV1"

showing 10 items of 134 documents

Reduced apoptosis of CD8+ T-Lymphocytes in the airways of smokers with mild/moderate COPD

2011

SummaryChronic obstructive pulmonary disease (COPD) is characterised by chronic inflammation in airways and lung parenchyma. CD8+ T-lymphocytes, crucial effector and regulatory cells in inflammation, are increased in the central and peripheral airways in COPD. The aim of this study was to assess the role of apoptosis in the accumulation of CD8+ T-lymphocytes within the airway wall in COPD. We examined the submucosa of transverse sections of central and peripheral airways from post-operative tissues from non-smokers (n = 16), smokers with normal lung function (n = 16), smokers with mild/moderate COPD (n = 16), and smokers with severe/very severe COPD (n = 9). TUNEL and immunohistochemistry t…

Pulmonary and Respiratory MedicineMaleapoptosis cytotoxic T-lymphocytes inflammation lung tissueInflammationApoptosisSettore MED/10 - Malattie Dell'Apparato RespiratorioCD8-Positive T-LymphocytesFEV1/FVC ratioPulmonary Disease Chronic ObstructiveSubmucosaForced Expiratory VolumeParenchymamedicineHumansLungLung tissueInflammationCOPDAnalysis of VarianceLungbusiness.industryCytotoxic T-lymphocytesSmokingMiddle Agedrespiratory systemmedicine.diseaseImmunohistochemistryrespiratory tract diseasesmedicine.anatomical_structureImmunologybehavior and behavior mechanismsFemalemedicine.symptomAirwaybusinessCD8Respiratory Medicine
researchProduct

Predictors of need for noninvasive ventilation during respiratory tract infections in medically stable, non-ventilated subjects with amyotrophic late…

2014

BACKGROUND: Acute lower respiratory infections can impair muscle strength in patients with amyotrophic lateral sclerosis (ALS). When associated with an increase in load on the respiratory system, this situation may precipitate hypercapnic respiratory failure in non-ventilated patients with ALS. The aim of this study was to determine whether a clinical or functional parameter can predict the need for noninvasive ventilation (NIV) during an acute respiratory infection for medically stable, non-ventilated patients with ALS. METHODS: This was a prospective study involving all non-ventilated subjects with ALS admitted due to an acute respiratory infection to a respiratory care unit from a tertia…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyNeuromuscular diseaseVital CapacityCritical Care and Intensive Care MedicineSeverity of Illness IndexFEV1/FVC ratioPredictive Value of TestsmedicineOdds RatioHumansProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedNoninvasive VentilationRespiratory tract infectionsbusiness.industryAmyotrophic Lateral SclerosisRespiratory infectionInsufflationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryLogistic ModelsRespiratory failureCoughAnesthesiaFemalebusinessRespiratory InsufficiencyRespiratory careRespiratory care
researchProduct

Direct effect of cigarette smoke on human pulmonary artery tension.

2010

The effect of chronic cigarette smoke on pulmonary artery (PA) tension has been studied extensively; nevertheless, the direct effect of cigarette smoke is poorly understood. We investigated the direct effect of cigarette smoke extract (CSE) on PA tension in non-smokers, smokers, and COPD patients in vitro. PA samples from 35 patients who underwent lung resection were examined by measuring isometric tension in response to increasing serotonin concentrations. CSE dose dependently inhibited the response to serotonin in smokers and COPD patients, and to a lesser extent in non-smokers. CSE-induced relaxation was similarly inhibited by the nonspecific nitric oxide synthase (NOS) inhibitor l-NOARG…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtySerotoninContraction (grammar)In Vitro TechniquesPulmonary ArteryNitroarginineMuscle Smooth VascularFEV1/FVC ratioPulmonary Disease Chronic ObstructiveEnosInternal medicinemedicine.arterySmokeparasitic diseasesTobaccomedicineHumansPharmacology (medical)5-HT receptorCOPDbiologyDose-Response Relationship Drugbusiness.industryLysineBiochemistry (medical)biology.organism_classificationmedicine.diseaserespiratory tract diseasesNitric oxide synthaseEndocrinologyAnesthesiaPulmonary arterybehavior and behavior mechanismsbiology.proteinFemaleSerotoninNitric Oxide SynthasebusinessMuscle ContractionPulmonary pharmacologytherapeutics
researchProduct

Kyphoscoliotic Ventilatory Insufficiency

2003

Objectives: To determine the effects of long-term nocturnal intermittent positive-pressure ventilation (NIPPV) on symptoms, pulmonary function test results, sleep, and respiratory muscle performance in patients with ventilatory insufficiency due to severe kyphoscoliosis. Design: A prospective study in which 16 severe kyphoscoliotic patients were treated with NIPPV delivered by volume-cycled and pressure-cycled ventilators, over a period of 36 months. Interventions and measurements: At baseline, pulmonary function tests, blood gas measurements, polysomnography, and respiratory muscle strength (measured by noninvasive indexes) were obtained. Symptoms and the number of hospitalizations in the …

Pulmonary and Respiratory MedicineMechanical ventilationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCritical Care and Intensive Care Medicinemedicine.diseasePulmonary function testingSurgeryHypoventilationFEV1/FVC ratioRespiratory failureAnesthesiamedicineRespiratory muscleBreathingmedicine.symptomCardiology and Cardiovascular MedicinebusinessKyphoscoliosisChest
researchProduct

2021

BackgroundThe prevalences of obstructive and restrictive spirometric phenotypes, and their relation to early-life risk factors from childhood to young adulthood remain poorly understood. The aim was to explore these phenotypes and associations with well-known respiratory risk factors across ages and populations in European cohorts.MethodsWe studied 49 334 participants from 14 population-based cohorts in different age groups (≤10, >10–15, >15–20, >20–25 years, and overall, 5–25 years). The obstructive phenotype was defined as forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) z-score less than the lower limit of normal (LLN), whereas the restrictive phenotype was def…

Pulmonary and Respiratory MedicinePregnancyPediatricsmedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationOdds ratiomedicine.diseaseFEV1/FVC ratiomedicineFamily historyYoung adulteducationbusinessBody mass indexAsthmaERJ Open Research
researchProduct

Quality Control of Spirometry in the Elderly

2000

We evaluated the outcome of the spirometry quality control program of the SA.R.A. multicenter project, the aim of which is the multidimensional assessment of asthma and COPD in the elderly ( ⩾ 65 yr). The factors determining this quality were also evaluated. The program was based on standardized procedures (ATS recommendations), performed by specifically trained and certified personnel; a fully-computerized spirometer with customized software was used for spirometry. A reference center made monthly controls. Overall, 638 cases and 984 controls were examined. Spirometric measurements were obtained in 607 cases and 912 controls; 508 and 747 tests with at least three acceptable curves were obt…

Pulmonary and Respiratory MedicineSpirometryCOPDReproducibilitymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryWalk distanceCritical Care and Intensive Care Medicinemedicine.diseaselaw.inventionFEV1/FVC ratiolawmedicinePhysical therapybusinessCognitive impairmentSpirometerAsthmaAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

A cross-sectional study assessing the relationship between BMI, asthma, atopy, and eNO among schoolchildren

2011

Increased body weight may influence airway inflammatory mechanisms.To assess whether overweight-obesity (OW-O), evaluated as increased body mass index, is associated either with exhaled nitric oxide (eNO), a marker of airway inflammation, or with allergic sensitization in a large sample of children and adolescents.A cross-sectional, epidemiological study was performed on a population sample of schoolchildren evaluating 708 subjects (age 10-16 years; BMI 13-39 kg/m(2)) by respiratory health questionnaire, skin prick tests, spirometry, and eNO measure.Prevalence rates were: OW-O 16.4%, asthma ever (A) 11.9%, and rhinoconjunctivitis (RC) 14.8%. Asthma ever and allergic sensitization were signi…

Pulmonary and Respiratory MedicineSpirometryMaleObesity; Vital Capacity; Humans; Asthma; Child; Body Mass Index; Sicily; Forced Expiratory Volume; Nitric Oxide; Cross-Sectional Studies; Rhinitis Allergic Perennial; Logistic Models; Adolescent; Female; Male; PrevalenceVital capacitymedicine.medical_specialtyRhinitis Allergic PerennialLogistic ModelAdolescentImmunologyVital CapacityNitric OxideBody Mass IndexAllergic sensitizationAtopyFEV1/FVC ratioInternal medicineForced Expiratory VolumemedicinePrevalenceImmunology and AllergyHumansObesityRisk factorChildSicilyAsthmaCross-Sectional Studiemedicine.diagnostic_testbusiness.industrymedicine.diseaseAsthmarespiratory tract diseasesCross-Sectional StudiesLogistic ModelsAnesthesiaExhaled nitric oxideFemalebusinessHuman
researchProduct

PD13 ‐ Gender differences in rhinitic children

2014

Gender differential effects on rhinitis are infrequently studied. Aim of our study is to assess gender differences in host and environmental characteristics and in rhinitis severity level within the IBIM Pulmonary and Allergy Pediatric Clinic. A series of rhinitic (R) patients (September 2011 - May 2013) were investigated through standardized questionnaire and spirometry. Statistical analyses were performed with SPSS. Preliminary results refer to 122 R patients: 77 males (M) (63.1%) and 45 females (F) (36.9%); age (years): 9.23 ± 3.42M vs 9.38 ± 3.02F; maternal history of rhinitis: 45.5%M vs 32.3%F (p<0.090); exposure to maternal smoking during pregnancy:15.6%M vs 2.2%F (p<0.021); exposure …

Pulmonary and Respiratory MedicineSpirometryPediatricsmedicine.medical_specialtyAllergymedicine.diagnostic_testbusiness.industryImmunologyOverweightmedicine.diseaseGastroenterology3. Good healthPulmonary function testingFEV1/FVC ratioInternal medicineImmunology and AllergyMedicinePoster Discussion PresentationRisk factormedicine.symptombusinessBreast feedingAsthmaClinical and Translational Allergy
researchProduct

Validation of FEV6 in the elderly: correlates of performance and repeatability.

2007

BACKGROUND: Forced expiratory volume in 6 s (FEV6) has been proposed as a more easily measurable parameter than forced vital capacity (FVC) to diagnose airway disease using spirometry. A study was undertaken to estimate FEV6 repeatability, to identify correlates of a good quality FEV6 measurement and of volumetric differences between FEV6 and FVC in elderly patients. METHODS: 1531 subjects aged 65-100 years enrolled in the SA.R.A project (a cross-sectional multicentre non-interventional study) were examined. FEV6 was measured on volume-time curves that achieved satisfactory start-of-test and end-of-test criteria. Correlates of FEV6 achievement were assessed by logistic regression. RESULTS: …

Pulmonary and Respiratory MedicineSpirometryVital capacitymedicine.medical_specialtyCross-sectional studyPopulationVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionFEV1/FVC ratioForced Expiratory VolumemedicineHumanseducationAgedAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryReproducibility of ResultsBronchial DiseasesRepeatabilityrespiratory systemAirway obstructionlung function agingmedicine.diseaserespiratory tract diseasesCross-Sectional StudiesPhysical therapybusiness
researchProduct

P191 QVA149 once daily improves exercise tolerance and lung function in patients with moderate to severe COPD: the BRIGHT study: Abstract P191 Table 1

2012

Introduction QVA149 is a novel once-daily fixed-dose combination of the long-acting β 2 -agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium (NVA237) in development for the treatment of chronic obstructive pulmonary disease (COPD). The BRIGHT study evaluated the effects of QVA149 versus placebo and tiotropium on exercise tolerance and lung function in patients with moderate-to-severe COPD. Methods In a double-blind, double-dummy, 3-period crossover study, patients with moderate-to-severe COPD were randomised to QVA149 110/50 µg, placebo or tiotropium 18 µg once daily for 3 weeks. The primary endpoint was exercise endurance time for QVA149 versus placebo during a sub…

Pulmonary and Respiratory MedicineVital capacityCOPDmedicine.medical_specialtyMuscle fatiguebusiness.industryPlacebomedicine.diseaseCrossover studyrespiratory tract diseasesFEV1/FVC ratioInternal medicinemedicineClinical endpointPhysical therapyCardiologyIndacaterolbusinessmedicine.drugThorax
researchProduct